Kenvue Inc. $KVUE Position Trimmed by Bank of New York Mellon Corp

Bank of New York Mellon Corp trimmed its stake in Kenvue Inc. (NYSE:KVUE) by 4.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,360,265 shares of the company’s stock after selling 1,254,065 shares during the quarter. Bank of New York Mellon Corp owned 1.58% of Kenvue worth $492,747,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in Kenvue by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 233,246,267 shares of the company’s stock worth $4,881,844,000 after buying an additional 4,101,880 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Kenvue by 1.2% during the 2nd quarter. Geode Capital Management LLC now owns 49,001,887 shares of the company’s stock valued at $1,021,267,000 after acquiring an additional 604,953 shares in the last quarter. Independent Franchise Partners LLP increased its stake in shares of Kenvue by 233.4% in the second quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock worth $654,388,000 after acquiring an additional 21,886,537 shares during the last quarter. American Century Companies Inc. raised its holdings in shares of Kenvue by 38.6% during the second quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock worth $633,447,000 after acquiring an additional 8,436,166 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Kenvue during the second quarter worth $537,418,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

KVUE has been the topic of several research reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Bank of America lowered their price target on Kenvue from $25.00 to $21.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Edward Jones lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Barclays boosted their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. Finally, JPMorgan Chase & Co. cut their price target on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $20.23.

Kenvue Stock Down 0.8%

Shares of Kenvue stock opened at $17.36 on Thursday. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The stock has a 50 day moving average price of $17.13 and a two-hundred day moving average price of $18.08. The stock has a market capitalization of $33.25 billion, a P/E ratio of 23.14 and a beta of 0.60.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. Kenvue’s revenue for the quarter was down 3.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently declared a dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be issued a dividend of $0.2075 per share. The ex-dividend date is Wednesday, February 11th. Kenvue’s dividend payout ratio is 110.67%.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The shares were bought at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the transaction, the director owned 27,307,632 shares in the company, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.17% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.